OncologySignalling and Cell Cycle Laboratory

Signalling and Cell Cycle Laboratory
<p>Angel R Nebreda</p>
Group Leader

ICREA Research Professor, ERC Advanced Grant

+34 93 40 31379

The Signalling and Cell Cycle Laboratory focuses on studying the basic mechanisms of cell regulation, especially regarding how external signals are interpreted by cells to modulate cell proliferation, differentiation and survival. Our research centers on two main subjects:

  1. Mechanisms of signal integration by p38 MAP kinases and their role in cancer
  2. Regulation and role of the RINGO/Speedy proteins, a new family of CDK activators.
Trempolec N, Muñoz JP, Slobodnyuk K, Marin S, Cascante M, Zorzano A and Nebreda AR.
Sci Rep, 7 (1), 11367 (2017)
Mikolcevic P, Isoda M, Shibuya H, del Barco Barrantes I, Igea A, Suja JA, Shackleton S, Watanabe Y and Nebreda AR.
Nat Commun, 7 11084 (2016)
Clemente-Ruiz M, Murillo-Maldonado JM, Benhra N, Barrio L, Pérez L, Quiroga G, Nebreda AR and Milán M.
Dev Cell, 36 (3), 290-302 (2016)
Igea A and Nebreda AR.
Cancer Res, 75 (19), 3997-4002 (2015)
Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG and Nebreda AR.
Cancer Cell, 25 (4), 484-500 (2014)
Urosevic J, Garcia-Albéniz X, Planet E, Real S, Céspedes MV, Guiu M, Fernandez E, Bellmunt A, Gawrzak S, Pavlovic M, Mangues R, Dolado I, Barriga FM, Nadal C, Kemeny N, Batlle E, Nebreda AR and Gomis RR.
Nat Cell Biol, 16 (7), 685-94 (2014)
Pereira L, Igea A, Canovas B, Dolado I and Nebreda AR.
EMBO Mol Med, 5 (11), 1759-1774 (2013)
Trempolec N, Dave-Coll N and Nebreda AR.
Cell, 152 (3), 656-657 (2013)
Trempolec N, Dave-Coll N and Nebreda AR.
Cell, 152 (4), 924-925 (2013)
del Barco Barrantes I, Coya JM, Maina F, Arthur JS and Nebreda AR.
P Natl Acad Sci Usa, 108 (31), 12764-9 (2011)
Cuadrado A and Nebreda AR.
Biochem J, 429 (3), 403-17 (2010)

The Signalling and cell cycle laboratory receives financial support from the following sources:

  • European Research Council
  • Generalitat de Catalunya (Government of Catalonia)
  • Ministerio de Economía y Competitividad (MINECO)
  • European Commission (EC), Fondo Europeo de Desarrollo Regional (FEDER), "Una manera de hacer Europa"

     

Group news & mentions

<p>Image of breast cancer cells derived from a mouse mammary tumour (in blue: nucleus, in green: tubulin) Author: Begoña Cánovas, IRB Barcelona</p>
24 May 2018

Greater knowledge of the mechanisms that contribute to the survival of tumour cells is key to vanquishing them.

<p>The image shows interactions between the androgen receptor protein (AR) and the TFIIF protein in red. (Author: Paula Martínez-Cristóbal)</p>
12 Dec 2017

In most cases, prostate cancer is cured by surgical removal of the tumour and/or by radiotherapy.

3 Oct 2017

The technology supplement Innovadores of the newspaper El Mundo has echoed on the award of 220,000 euros to three biomedical innovation projects underway at IRB Barcelona.

29 Sep 2017

The Catalan’ Government’s Agency for Management and of University and Research Grants (Agencia de Gestió i Ajuts Universitaris i de Recerca (AGAUR)) has awarded around 220,000 euros to thr

Upcoming events

25 May
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Prof. Dr. Martin Eilers. Department of Biochemistry and Molecular Biology Biocenter, University of Würzburg. Würzburg, Germany
30 May
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Soraia Mendes, IBMB-CSIC
30 May
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Carlos Fernández-Hernando, PhD - Associate Professor (Tenure). Vascular Biology & Therapeutics Program (VBT) Departments of Comparative Medicine and Pathology Integrative Cell Signaling & Neurobiology Metabolism Program (ICSNM) Yale University School of M